Guardant Health (GH) Reports Q3 Loss, Beats Revenue Estimates

Guardant Health (GH) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of$ 0.48. This compares to a loss of $0.45 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +18.75%. A quarter ago, it was expected that this provider of oncology testing services would post a loss of$ 0.52 per share when it actually produced a loss of $0.44, delivering a surprise of +15.38%.Over the last four qu ...